An observational study in Uterine Fibroid, sponsored by Karolinska Institutet. Status unknown at 1 site in Sweden. Open to female participants aged 25 Years and older. Per ClinicalTrials.gov, last updated 2023-05-01.
Sponsored by Karolinska Institutet · Observational
This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment of symptoms related to uterine fibroids. We will include 200 women.
490 studies on the registry are indexed under Leiomyoma; 81 are open to participants now.
This study's planned enrollment of 200 is above the median of 150 across 119 observational studies indexed under Leiomyoma.
Browse Leiomyoma studies →Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with symptoms from uterine fibroids
Exclusion Criteria:
Symptom severity of uterine fibroids
Score of validated form Uterine Fibroid symptom- Quality of Life questionnaire. minumum 0, maximum 100 where higher scores indicate higher symptom severity
Time frame: 6 months post treatment
Quality of Life score
Score of validated form Uterine Fibroid symptom- Quality of Life questionnaire.minumum 0, maximum 100 where higher scores indicate higher quality of life
Time frame: 6 months post treatment
menstrual bleeding
Score on validated Pictorial Bleeding assessment chart. minimum 1, no maximum. higher scores indicate more bleeding.
Time frame: 6 months post treatment
acceptability
Answer to question: if you were to recommend the treatment to a friend on a scale from 1-7 where 7 is the highest rating- what would you say.
Time frame: 2 hours post treatment and 6 months post treatment (+/- 2 weeks)
This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska Institutet